Late feasibility of novel methods for improved polyketide drug development
Lead Participant:
ISOMERASE THERAPEUTICS LIMITED
Abstract
Confirmation of scaleability of new tools for accessing novel natural products with use in human and
animal health and as agrochemicals.
animal health and as agrochemicals.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| ISOMERASE THERAPEUTICS LIMITED | £342,587 | £ 239,811 |
Participant |
||
| JOHN INNES CENTRE | £91,979 | £ 91,979 |
| INNOVATE UK |
People |
ORCID iD |
| Lesley Sheehan (Project Manager) |